ES366173A1 - Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo. - Google Patents
Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo.Info
- Publication number
- ES366173A1 ES366173A1 ES366173A ES366173A ES366173A1 ES 366173 A1 ES366173 A1 ES 366173A1 ES 366173 A ES366173 A ES 366173A ES 366173 A ES366173 A ES 366173A ES 366173 A1 ES366173 A1 ES 366173A1
- Authority
- ES
- Spain
- Prior art keywords
- antacid
- composition
- viscosity
- gelation agent
- gelation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title abstract 6
- 229940069428 antacid Drugs 0.000 title abstract 6
- 239000003159 antacid agent Substances 0.000 title abstract 6
- 230000001458 anti-acid effect Effects 0.000 title abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 238000001879 gelation Methods 0.000 abstract 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- 239000007900 aqueous suspension Substances 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910020335 Na3 PO4.12H2 O Inorganic materials 0.000 abstract 1
- JPKKQJKQTPNWTR-KQAYXBCTSA-N [(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2r)-3-hydroxy-2-phenylpropanoate;sulfuric acid;hydrate Chemical compound O.OS(O)(=O)=O.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 JPKKQJKQTPNWTR-KQAYXBCTSA-N 0.000 abstract 1
- 229940124326 anaesthetic agent Drugs 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 229940124575 antispasmodic agent Drugs 0.000 abstract 1
- GUBNMFJOJGDCEL-UHFFFAOYSA-N dicyclomine hydrochloride Chemical compound [Cl-].C1CCCCC1C1(C(=O)OCC[NH+](CC)CC)CCCCC1 GUBNMFJOJGDCEL-UHFFFAOYSA-N 0.000 abstract 1
- 229940110321 dicyclomine hydrochloride Drugs 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000000750 progressive effect Effects 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229940072358 xylocaine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72217668A | 1968-04-18 | 1968-04-18 | |
| US78572768A | 1968-12-20 | 1968-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES366173A1 true ES366173A1 (es) | 1971-04-01 |
Family
ID=27110553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES366173A Expired ES366173A1 (es) | 1968-04-18 | 1969-04-17 | Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS4621672B1 (esLanguage) |
| AU (1) | AU438147B2 (esLanguage) |
| BE (1) | BE731695A (esLanguage) |
| CA (1) | CA959760A (esLanguage) |
| CH (1) | CH536114A (esLanguage) |
| DE (1) | DE1919802A1 (esLanguage) |
| DK (1) | DK127269B (esLanguage) |
| ES (1) | ES366173A1 (esLanguage) |
| FI (1) | FI50831C (esLanguage) |
| FR (1) | FR2007475A1 (esLanguage) |
| GB (1) | GB1269987A (esLanguage) |
| IL (1) | IL32020A (esLanguage) |
| NL (1) | NL6906087A (esLanguage) |
| NO (1) | NO129077B (esLanguage) |
| SE (1) | SE388356B (esLanguage) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1401256A (en) * | 1972-06-30 | 1975-07-16 | Miles Lab | Anticid tablet and preparation thereof |
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| SE7905972L (sv) * | 1979-07-09 | 1981-01-10 | Haessle Ab | Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand |
| AU590578B2 (en) * | 1985-04-18 | 1989-11-09 | Procter & Gamble Company, The | Treatment of non-ulcer dyspepsia with bismuth salts |
| IT1215332B (it) * | 1987-01-12 | 1990-02-08 | Crinos Industria Farmaco | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
| DE3812378A1 (de) * | 1988-04-14 | 1989-10-26 | Theo Mertens | Mobile erntegutmahl- und -mischvorrichtung |
| US4988679A (en) * | 1989-01-03 | 1991-01-29 | Leonard Chavkin | Liquid sustained release composition |
| US4980175A (en) * | 1989-01-03 | 1990-12-25 | Leonard Chavkin | Liquid orally administrable compositions based on edible oils |
| DE4305919A1 (de) * | 1993-02-26 | 1994-09-01 | Ruediger Potthoff | Transportsilo für Kunststoff-Granulat |
| AU2003210812A1 (en) * | 2002-02-04 | 2003-09-02 | Pharmacia Corporation | Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| CN1638804A (zh) * | 2002-03-04 | 2005-07-13 | 美德阿利克斯株式会社 | 在生物体内相转移的液态基质以及液态口服制剂 |
| US20030232092A1 (en) * | 2002-06-14 | 2003-12-18 | Hasenmayer Donald L. | Liquid antacid compositions |
| EP3137059B1 (en) | 2014-04-29 | 2018-05-23 | The Procter and Gamble Company | Method for making bismuth-containing liquid pharmaceutical suspensions |
| US9486460B2 (en) | 2014-04-29 | 2016-11-08 | The Procter & Gamble Company | Bismuth containing liquid pharmaceutical suspensions |
| CN114732828A (zh) * | 2022-04-27 | 2022-07-12 | 广西南宁百会药业集团有限公司 | 一种铝碳酸镁混悬液及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE621147A (esLanguage) * |
-
1969
- 1969-04-14 IL IL32020A patent/IL32020A/en unknown
- 1969-04-14 GB GB09070/69A patent/GB1269987A/en not_active Expired
- 1969-04-15 NO NO1526/69A patent/NO129077B/no unknown
- 1969-04-15 FI FI691089A patent/FI50831C/fi active
- 1969-04-16 CA CA048,813A patent/CA959760A/en not_active Expired
- 1969-04-16 AU AU53539/69A patent/AU438147B2/en not_active Expired
- 1969-04-17 ES ES366173A patent/ES366173A1/es not_active Expired
- 1969-04-17 DK DK209369AA patent/DK127269B/da unknown
- 1969-04-18 SE SE6905549A patent/SE388356B/xx unknown
- 1969-04-18 CH CH593269A patent/CH536114A/fr not_active IP Right Cessation
- 1969-04-18 FR FR6912182A patent/FR2007475A1/fr not_active Withdrawn
- 1969-04-18 NL NL6906087A patent/NL6906087A/xx unknown
- 1969-04-18 JP JP3015469A patent/JPS4621672B1/ja active Pending
- 1969-04-18 BE BE731695D patent/BE731695A/xx unknown
- 1969-04-18 DE DE19691919802 patent/DE1919802A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2007475A1 (esLanguage) | 1970-01-09 |
| IL32020A0 (en) | 1969-06-25 |
| CA959760A (en) | 1974-12-24 |
| FI50831C (fi) | 1976-08-10 |
| DK127269B (da) | 1973-10-15 |
| JPS4621672B1 (esLanguage) | 1971-06-19 |
| CH536114A (fr) | 1973-04-30 |
| SE388356B (sv) | 1976-10-04 |
| NO129077B (esLanguage) | 1974-02-25 |
| AU438147B2 (en) | 1973-07-18 |
| BE731695A (esLanguage) | 1969-10-20 |
| DE1919802A1 (de) | 1969-11-06 |
| GB1269987A (en) | 1972-04-12 |
| IL32020A (en) | 1972-11-28 |
| NL6906087A (esLanguage) | 1969-10-21 |
| FI50831B (esLanguage) | 1976-04-30 |
| AU5353969A (en) | 1970-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES366173A1 (es) | Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo. | |
| GB1340516A (en) | Ophthalmic solution | |
| US3171752A (en) | Contact lens treating solution | |
| US2550622A (en) | Ointment base and iodine ointment | |
| AU697767B2 (en) | Topically applicable pharmaceutical composition, process of manufacture, and use of the composition | |
| US3574854A (en) | Method for soothing the skin with a cream containing sodium chloride | |
| DE69401502D1 (de) | Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält | |
| US2857311A (en) | Dermatological mixture of ion-exchange resins | |
| Iwadare | ζ-Potentials of Synthetic Fibers in Aqueous Solutions of Sodium Alkyl Sulfates and Viscosities of Their Solutions | |
| GB1325268A (en) | Oxymethylene polymer -silica compositions | |
| ATE69384T1 (de) | Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen. | |
| GB1512148A (en) | Iodophor solution | |
| US1495308A (en) | James m | |
| US2798816A (en) | Permanently sterilized dental material | |
| JP3105302B2 (ja) | クリーム基剤 | |
| GB1132576A (en) | X-ray contrast media | |
| KR860003333A (ko) | 나트륨 트리폴리포스 페이트의 제조방법 | |
| ES296805A1 (es) | Procedimiento para la preparaciën de una composiciën para la higiene de la piel | |
| ES396666A1 (es) | Mejoras introducidas en un metodo para la preparacion de una pasta dentifrica. | |
| US2115848A (en) | Ephedrine composition | |
| US2511740A (en) | Stabilized thixotrpic gels | |
| US915977A (en) | Process of obtaining strong aqueous solutions of creosote. | |
| US2741574A (en) | Stable aqueous injectable procaine hydrochloride aminophylline preparation | |
| US2603586A (en) | Radiopaque formulation | |
| KR880701100A (ko) | 감기치료용 키트, 감기치료용 약제 및 이의 용도 |